Human medicines European public assessment report (EPAR): Deferasirox Accord, deferasirox, Iron Overload;beta-Thalassemia, Date of ...
Deferasirox Accord is indicated for the treatment of chronic iron overload due to frequent blood transfusions (≥7 ml/kg/month of packed red blood cells) in patients with beta thalassaemia major aged 6 years and older. Deferasirox Accord is also indicated …